
Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideo
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2023 Pride Publishing Inc.
All Rights reserved
All Rights reserved
Don’t miss our latest news! Sign up today for our free newsletter.
By continuing to use our site, you agree to our Private Policy and Terms of Use.
HIVers whose virus uses CXCR4 receptors to infect immune system cells'either alone or in combination with CCR5 receptors'experience more rapid CD4-cell loss and a greater risk of illness than those infected with only CCR5 strains, researchers report in the journal Clinical Infectious Diseases. --------------------- For the first time, U.S. researchers have witnessed and recorded the assembly of a complete HIV viral copy inside an infected immune system cell, reports the journal Nature. They hope to use their observations to identify new ways to thwart the viral-assembly process. --------------------- Phase III clinical trial data from NeurogesX's neuropathy treatment NGX-4010 have shown that the product, a skin patch containing capsaicin (the compound that gives chili peppers their heat), is effective in reducing neuropathy-related pain. Users reported a mean pain reduction of 22.8% that lasted 12 weeks or longer from a single patch application. --------------------- HIVers taking Kaletra should not also take the lipid-lowering medication Crestor, researchers warn in the Journal of Acquired Immune Deficiency Syndromes. Interaction between the medications deceases Crestor's ability to lower LDL cholesterol levels. --------------------- A regimen of Trizivir plus Viread is effective in lowering viral levels in adults with multidrug-resistant infections, Spanish researchers report in HIV Medicine. --------------------- Australian researchers are beginning human studies of a therapeutic vaccine that uses key HIV proteins to train the immune system to recognize and attack the virus. --------------------- A too-rigorous immune system reactivation through antiretroviral treatment could hamper the effectiveness of anti-HIV salvage regimens and lower the chances for reducing viral levels, according to a study in the Journal of Acquired Immune Deficiency Syndromes. Monitoring blood-based levels of proteins showing elevated immune activation may help predict response to therapy much better than standard viral load and CD4-cell tests, the researchers say.
Want more breaking equality news & trending entertainment stories?
Check out our NEW 24/7 streaming service: the Advocate Channel!
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Don’t miss our latest news! Sign up today for our free newsletter.
Plus: Featured Video
Latest Stories
‘Kokomo City’ Gives a Searing Look Into Lives of Black Trans Sex Workers
August 18 2023 12:40 PM